The mRNA interactors of these lncRNAs map to axon guidance and neurotrophin signaling pathway (SAPCD1-AS1), pathways in cancer (PINK1-AS, SNHG16), p53 signaling pathway (RP11-9819.4, SNHG16) and neurodegeneration (LINC00657). This evidence concerns the gene PTGDR and cancer.